Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma
Open Access
- 12 January 2023
- journal article
- research article
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 29 (2) , 205-211
Abstract
PURPOSETo explore the utility of four-phase computed tomography (CT) in distinguishing renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma (ccRCC).METHODSEighteen patients with oncocytoma and 63 patients with ccRCC presenting with central hypodense areas were included in this study. All patients underwent four-phase CT imaging including the ex-cretory phases later than 20 min after contrast injection. Two blinded experienced radiologists vi-sually reviewed the enhancement features of the central hypodense areas in the excretory phase images and selected the area demonstrating the greatest degree of enhancement of the tumor in the corticomedullary phase images. Regions of interest (ROIs) were placed in the same location in each of the three contrast-enhanced imaging phases. Additionally, ROIs were placed in the adja-cent normal renal cortex for normalization. The ratio of the lesion to cortex attenuation (L/C) for the three contrast-enhanced imaging phases and absolute de-enhancement were calculated. The receiver operating characteristic curve was used to obtain the cut-off values.RESULTSComplete enhancement inversion of the central areas was observed in 12 oncocytomas (66.67%) and 16 ccRCCs (25.40%) (P = 0.003). Complete enhancement inversion combined with L/C in the corticomedullary phase lower than 1.0 (P < 0.001) or absolute de-enhancement lower than 42.5 HU (P < 0.001) provided 86.42% and 85.19% accuracy, 61.11% and 55.56% sensitivity, 93.65% and 93.65% specificity, 73.33% and 71.43% positive predictive value (PPV), and 89.39% and 88.06% negative predictive value (NPV), respectively, for the diagnosis of oncocytomas. Combined with complete enhancement inversion, L/C in the corticomedullary phase lower than 1.0 and absolute de-enhancement lower than 42.5 HU provided 87.65%, 55.56%, 96.83%, 83.33%, and 88.41% of accuracy, sensitivity, specificity, PPV, and NPV, respectively, for the diagnosis of oncocytomas.CONCLUSIONThe combination of enhancement features of the central hypodense areas and the peripheral tu-mor parenchyma can help distinguish oncocytoma with central hypodense areas from ccRCC.Keywords
This publication has 22 references indexed in Scilit:
- CT and MR imaging for solid renal mass characterizationEuropean Journal of Radiology, 2018
- Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomasEuropean Radiology, 2017
- Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytomaAbdominal Radiology, 2016
- Differentiation of Renal Oncocytoma and Renal Clear Cell Carcinoma Using Relative CT Enhancement RatioChinese Medical Journal, 2015
- Qualitative and Quantitative MDCT Features for Differentiating Clear Cell Renal Cell Carcinoma From Other Solid Renal Cortical MassesAmerican Journal of Roentgenology, 2014
- Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approachesInternational Urology and Nephrology, 2014
- Combined Late Gadolinium-Enhanced and Double-Echo Chemical-Shift MRI Help to Differentiate Renal Oncocytomas With High Central T2 Signal Intensity From Renal Cell CarcinomasAmerican Journal of Roentgenology, 2013
- Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomographyWorld Journal of Urology, 2010
- Segmental Enhancement Inversion at Biphasic Multidetector CT: Characteristic Finding of Small Renal OncocytomaRadiology, 2009
- Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasmsClinical Radiology, 2009